• November 18-20, 2019 | Crowne Plaza Boston - Newton, Boston, MA
  • Toll Free: +1 844 395 4102

Silver Sponsor

ForteBio

ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer products that span multiple technology vectors including analytical instrumentation and software, clone picking and imaging, and, automation and customization engineering solutions. Our customers perform crucial work in life sciences research across academic, government and industrial settings, including pharmaceutical research, development, and manufacturing.   http://www.fortebio.com/

Exhibitor

New England Peptide

New England Peptide prides itself on providing top-notch peptides and excellent customer service. We strive to constantly better ourselves and, in the process, the industry. Our company is built around the vision of providing high-quality peptides and antibodies. Our goal is to change the industry with straightforward communication and consistent on-time deliveries, culminating in the highest degree of customer satisfaction in the business.   https://www.newenglandpeptide.com/

Supporting Sponsor

InDevR

InDevR, Inc. is a leader in providing progressive analytical technologies that enhance and accelerate vaccine characterization and production. The company is committed to developing next-generation diagnostic products that will enable unprecedented tracking of seasonal and emerging influenza viruses around the globe.   https://indevr.com/

Become a Sponsor

Keynote SpeakersVaccines R&D-2019

Rino Rappuoli

Rino Rappuoli

Chief Scientist & Head of External Research and Development, GSK Vaccines

John R. Mascola

John R. Mascola

Director, Vaccine Research Center, NIH/NIAID

Jay A. Berzofsky

Jay A. Berzofsky

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Dan H. Barouch

Dan H. Barouch

Director, HMFP - Division of Vaccine Research

Michel De Wilde

Michel De Wilde

Former Senior Vice President R&D of Sanofi Pasteur & Owner, MDW Consultant LLC

Penny M. Heaton

Penny M. Heaton

Chief Executive Officer, Bill & Melinda Gates Medical Research Institute

Stephen L. Hoffman

Stephen L. Hoffman

Chief Executive and Scientific Officer, Sanaria Inc.

Kathy L. Rowlen

Kathy L. Rowlen

Chief Executive and Scientific Officer, InDevR, Inc.

Nancy Sullivan

Nancy Sullivan

Chief, Biodefense Research Section, NIH/NIAID

Nathalie Garçon

Nathalie Garçon

Chief Executive and Scientific Officer, IRT BIOASTER

Peter L. Nara

Peter L. Nara

Chairman Emeritus. Chief Executive Officer, President, Chairman & co-founder, Biological Mimetics, Inc.

Norman W. Baylor

Norman W. Baylor

President and Chief Executive Officer, Biologics Consulting

Robert-W-Malone

Robert W. Malone

RW Malone MD, LLC: Consultancy and Analytics in the Biosector

Denise L. Faustman

Denise L. Faustman

Director of Immunobiology, Massachusetts General Hospital, Boston, MA

Early Bird Deadline
Extended
(June 21, 2019) Fast & Easy Online Registration

Group (3 Members)

$ 3000 $ 4700

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Delegate

$ 1199 $ 1799

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Industry/Company

$ 1099 $ 1699

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

Academic/Federal

$ 999 $ 1599

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Register

2014

Year of Foundation

765

Speakers

125

Business Partners

150

Happy Clients

Testimonials Vaccines R&D-2018

logo1
logo1
logo1
logo1
logo1
logo1

From Our BlogVaccines R&D Blogger

Vaccines R&D-2019
COLOMBIAN MALARIA VACCINE, TO TRIALS IN AFRICA ANNOUNCEMENT WAS MADE AT VACCINES R&D-2016

After 35 years of research, the Colombian scientist Manuel Elkin Patarroyo and his team at the Institute of Immunology of Colombia (FIDIC) s Foundation and ready for human testing its new vaccine against malaria in seven countries in sub – Saharan Africa.

Vaccines R&D-2019
REPORT ON THE 3RD INTERNATIONAL CONFERENCE ON VACCINES RESEARCH

The 3rd International Conference on Vaccines Research and Development (Vaccines R&D 2017) at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area, brought together more than 250 experts of the leading institutes and organizations to share their knowledge.